Thyrocare Technologies Reports Strong Growth in Q2 FY26

Thyrocare Technologies achieves remarkable results in the second quarter of FY26, showcasing significant advancements in both revenue and profit, bolstered by increased testing volumes across its diagnostic and imaging sectors. The company’s consolidated revenue from operations increased by 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26, up from Rs 177.36 crore in Q2 FY25, as stated in its filings with the stock exchanges. On a sequential basis, revenue grew by 12% from Rs 193 crore in Q1 FY26.

Key Growth Drivers of Thyrocare Technologies

The primary growth factor stemmed from the diagnostic testing services segment, which accounted for over 93% of total revenue. Additionally, the imaging services segment, including PET-CT and radiopharmaceuticals, contributed Rs 14.2 crore during the quarter.

Profit and Margin Improvements

Thyrocare’s profit after tax soared by 81% YoY to Rs 47.9 crore in Q2 FY26, compared to Rs 26.4 crore in the same period last year, supported by margin expansion and operational efficiencies. For the first half of FY26, the net profit surged by 71% to Rs 86.1 crore, up from Rs 50.4 crore in H1 FY25.

Financial Metrics

The company’s EBITDA margin enhanced to 33%, with total expenses increasing at a slower rate (10% YoY) compared to revenue growth. In the quarter, the cost of materials consumed reached Rs 59.8 crore, while employee benefits expenses amounted to Rs 33.2 crore.

Shareholder Benefits

The board of Thyrocare has sanctioned a 2:1 bonus issue, issuing two fully paid-up shares for each existing share held by shareholders as of the record date. Additionally, an interim dividend of Rs 7 per share for FY26 has been declared, with October 24 set as the record date.

Current Assets and Market Performance

As of the end of H1 FY26, Thyrocare reported total current assets of Rs 323 crore, which includes cash and bank balances of Rs 70 crore. The company’s shares are currently trading at Rs 1270.5 (as of 12.35 PM) with a total market capitalisation of Rs 6,754 crore ($767 million).